Sarepta therapeutics to present new data from its neuromuscular portfolio at 2024 world muscle society congress

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, will present at the 29th annual congress of the world muscle society 2024 congress (wms 2024), taking place oct. 8-12, 2024, in prague, czechia. among the data to be presented are new safety and efficacy results from several studies in the delandistrogene moxeparvovec clinical development program, including data from studies 9001-101, 9001-103 (endeavor) and 9.
SRPT Ratings Summary
SRPT Quant Ranking